Quantbot Technologies’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Quantbot Technologies's INO Position: Q4 2022 in Review
Quantbot Technologies sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 11,205 shares — an estimated $231K sold.
Quantbot Technologies first reported a position in INO in Q2 2014 and held it in 15 quarters. The position peaked at $258K in Q4 2021. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.
- Quantbot Technologies reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Quantbot Technologies sold 11,205 Inovio Pharmaceuticals shares in Q4 2022, an estimated $231K.
- Quantbot Technologies first reported a position in Inovio Pharmaceuticals in Q2 2014 and held it in 15 quarters.
- Quantbot Technologies's Inovio Pharmaceuticals position peaked at $258K in Q4 2021.
- 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.
Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.